Effects of Egoscue Exercises in Patients With Knee Osteoarthritis
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Jul 3, 2025
Trial Information
Current as of July 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new type of exercise program called Egoscue Exercises to help people with knee osteoarthritis, a common condition where the knee joint becomes painful and stiff. The goal is to see if these exercises can improve symptoms and help manage the condition in a way that might reduce the need for medications, which can sometimes have side effects.
The study is looking for men and women between the ages of 45 and 65 who have been diagnosed with moderate knee osteoarthritis and have a body weight above a certain level (a BMI over 25). People with very mild or very severe knee osteoarthritis, or those currently receiving steroid treatments or joint injections, will not be able to join. Participants in the study can expect to try the Egoscue Exercises, which are designed to improve movement and reduce pain, and their progress will be monitored to see how well the exercises work. This trial is not yet recruiting but aims to offer a new option for managing knee osteoarthritis beyond traditional drug treatments.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age group between 45 and 65 years ,
- • Both genders male and female ,
- • BMI ˃ 25 , and Knee OA clinically or radiologically diagnosed by Kellgren-Lawrence Method, Grade II and III
- Exclusion Criteria:
- • Age less than 45 years or older than 65 years,
- • BMI \< 25, Knee OA in grade I and IV, and
- • Patients on steroid therapy and intra articular injection
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sahiwal, Punjab, Pakistan
Patients applied
Trial Officials
Samrood Akram, PhD*
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported